DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Pegasys (Peginterferon Alfa-2A) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (71)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Pegasys (Peginterferon Alfa-2A) disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 71   Next >>

Possible Pegasys side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Dyspnoea, Chest Discomfort, Anaemia, Blood Pressure Decreased, Asthenia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Dosage: unk
    Start date: 2012-05-16

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-05-16

Victrelis
    Dosage: 200 mg, tid
    Administration route: Oral
    Start date: 2012-06-27
    End date: 2012-07-03

Other drugs received by patient: Imdur; Aspirin; Calcium 500; Vitamin B Complex CAP; Metoprolol Tartrate; Hydralazine HCL; Fish OIL; Tricor; Cardura; Procardia XL; Lasix



Possible Pegasys side effects in male

Reported by a physician from United States on 2012-08-17

Patient: male, weighing 65.4 kg (143.8 pounds)

Reactions: Renal Failure

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Incivek
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-19

Pegasys
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-19

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-19

Other drugs received by patient: Zantac; Lisinopril; Ramipril



Possible Pegasys side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-16

Patient: male

Reactions: Drug Ineffective, Deafness Unilateral, Dizziness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-07-20

Victrelis
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-07-20



Possible Pegasys side effects in male

Reported by a physician from Australia on 2012-08-14

Patient: male, weighing 88.0 kg (193.6 pounds)

Reactions: Deafness Neurosensory

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-12
    End date: 2012-01-24

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-12
    End date: 2012-01-28

Other drugs received by patient: Fungilin; Pristiq



Possible Pegasys side effects in female

Reported by a physician from Israel on 2012-08-13

Patient: female

Reactions: Neuropathy Peripheral, Cryoglobulinaemia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Dosage: date of last dose prior to sae: 20/feb/2012
    Indication: Hepatitis C
    Start date: 2011-03-27
    End date: 2012-02-20

Pegasys
    Dosage: date of last dose prior to sae: 20/feb/2012
    Indication: Hepatitis C
    Start date: 2011-03-27
    End date: 2012-02-20

Other drugs received by patient: Levothyroxine Sodium; Betacorten; Brimonidine Tartrate



Possible Pegasys side effects in

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-10

Patient:

Reactions: Bronchitis Bacterial, Anaemia, Pancytopenia, Myocardial Infarction, Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Dosage: 400-800 mg
    Administration route: Oral

Pegasys

Victrelis
    Administration route: Oral

Other drugs received by patient: Doxycycline HCL



Possible Pegasys side effects in male

Reported by a physician from United States on 2012-08-02

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Pericarditis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2011-07-08

Copegus
    Start date: 2012-06-04

Pegasys
    Dosage: reduced dosage
    Start date: 2012-03-20
    End date: 2012-05-28

Pegasys
    Start date: 2012-05-28

Pegasys
    Dosage: reduced dosage
    Start date: 2012-02-06
    End date: 2012-03-20

Pegasys
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2012-02-06

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: loading dose
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2012-06-04



Possible Pegasys side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient:

Reactions: Polyneuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Copegus
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01
    End date: 2012-03-14

Pegasys
    Dosage: 130 microgram, unk
    Indication: Hepatitis C
    Start date: 2012-01-01
    End date: 2012-03-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-29
    End date: 2012-03-14



Possible Pegasys side effects in male

Reported by a physician from France on 2012-07-27

Patient: male

Reactions: Polyneuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-03-14

Copegus
    Indication: Product Used FOR Unknown Indication

Pegasys
    Start date: 2012-01-01
    End date: 2012-03-14

Pegasys
    Indication: Product Used FOR Unknown Indication

Victrelis
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-29
    End date: 2012-03-14



Possible Pegasys side effects in female

Reported by a physician from United States on 2012-07-27

Patient: female, weighing 64.5 kg (141.9 pounds)

Reactions: Emotional Distress

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Blinded RO 5466731 (Hcv Ns5b Inhibitor)
    Indication: Hepatitis C
    Start date: 2011-06-07
    End date: 2011-08-24

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-06-07
    End date: 2011-08-24

Pegasys
    Indication: Hepatitis C
    Start date: 2011-06-07
    End date: 2011-08-24

Other drugs received by patient: Vitamin D; Advil; Nexium; Lamotrigine



Possible Pegasys side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: female

Reactions: Confusional State, Disorientation

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribasphere
    Indication: Product Used FOR Unknown Indication

Victrelis
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01



Possible Pegasys side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-20

Patient: 62 year old female

Reactions: Confusional State, Activities of Daily Living Impaired, Disorientation

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg, capsule, three times a day, oral
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01



Possible Pegasys side effects in male

Reported by a physician from Germany on 2012-07-19

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Germ Cell Cancer

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-03

Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-19
    End date: 2012-03-03

Other drugs received by patient: Methadone HCL



Possible Pegasys side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-19

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Adverse Event

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Incivek
    Dosage: 2 tablets 7-9 hrs apart

Pegasys
    Indication: Hepatitis C
    Start date: 2011-09-03
    End date: 2012-05-13

Pegasys
    Indication: Disease Recurrence
    Start date: 2011-09-03
    End date: 2012-05-13

Ribavirin
    Dosage: (6) a day

Victrelis
    Dosage: 12 a day



Possible Pegasys side effects in male

Reported by a physician from Japan on 2012-07-10

Patient: male

Reactions: Blood Pressure Increased, Malaise, Cerebral Haemorrhage

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Mircera
    Indication: Nephrogenic Anaemia
    Start date: 2012-05-01

Pegasys
    Dosage: dosage is uncertain.
    Indication: Hepatitis C
    Start date: 2011-10-07



Possible Pegasys side effects in male

Reported by a physician from United States on 2012-07-05

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Pericarditis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2011-07-08

Copegus
    Start date: 2012-06-04

Pegasys
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2012-02-06

Pegasys
    Dosage: reduced dosage
    Start date: 2012-02-06
    End date: 2012-05-28

Pegasys
    Start date: 2012-05-28

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: loading dose
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2012-06-04



Possible Pegasys side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: male

Reactions: Dysgeusia, Chest Discomfort, Dyspnoea, Fatigue, Nausea, Anaemia, Chest Pain

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribasphere
    Indication: Product Used FOR Unknown Indication

Victrelis
    Administration route: Oral
    Indication: Hepatitis C



Possible Pegasys side effects in 53 year old male

Reported by a pharmacist from Canada on 2012-06-26

Patient: 53 year old male, weighing 63.6 kg (139.8 pounds)

Reactions: Speech Disorder, Haemorrhage Intracranial, Gait Disturbance, Hemiplegia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Pegasys side effects in 60 year old male

Reported by a pharmacist from United States on 2012-06-26

Patient: 60 year old male

Reactions: Angioedema

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 mcg;qw;
    Indication: Hepatitis C

Ribavirin
    Dosage: 500 mg;bid;
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg;q8h; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-04

Other drugs received by patient: Acetaminophen; Lactulose; Hydrochlorothiazide; Lisinopril



Possible Pegasys side effects in male

Reported by a physician from Germany on 2012-06-25

Patient: male, weighing 82.0 kg (180.4 pounds)

Reactions: Retinal Vein Occlusion, Macular Oedema

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Boceprevir
    Indication: Hepatitis C

Copegus
    Indication: Hepatitis C
    Start date: 2011-09-29

Pegasys
    Indication: Hepatitis C
    Start date: 2011-09-29



Possible Pegasys side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-13

Patient: 51 year old female

Reactions: Dysgeusia, Mental Impairment, Hepatic Pain, Fatigue, Anaemia, Influenza Like Illness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Dosage: 80 mcg
    Indication: Product Used FOR Unknown Indication

Ribasphere
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-01



Possible Pegasys side effects in 50 year old male

Reported by a consumer/non-health professional from Germany on 2012-06-11

Patient: 50 year old male, weighing 84.0 kg (184.8 pounds)

Reactions: Bronchitis Bacterial, Anaemia, Pancytopenia, Myocardial Infarction, Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Boceprevir
    Start date: 2012-02-14
    End date: 2012-03-26

Boceprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-14
    End date: 2012-03-26

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-14
    End date: 2012-03-26

Copegus
    Dosage: 400-800 mg
    Start date: 2012-01-14
    End date: 2012-03-26

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-14
    End date: 2012-03-21

Other drugs received by patient: Doxycycline



Possible Pegasys side effects in male

Reported by a physician from Spain on 2012-06-08

Patient: male

Reactions: Erectile Dysfunction

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-02-25
    End date: 2011-09-07

Ribavirin
    Dosage: dosage: 1200 units not reported
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-02-25
    End date: 2011-09-07



Possible Pegasys side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-07

Patient: female, weighing 84.5 kg (185.9 pounds)

Reactions: B-Cell Lymphoma Stage IV, Pneumonia, Pulmonary Vasculitis, Pancytopenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-27

Copegus
    Start date: 2011-07-05
    End date: 2011-07-05

Copegus
    Administration route: Oral
    Start date: 2011-04-27
    End date: 2011-05-10

Copegus
    Start date: 2011-07-05

Copegus
    Administration route: Oral
    Start date: 2011-05-10
    End date: 2011-07-05

Pegasys
    Start date: 2011-04-20
    End date: 2011-06-29

Pegasys
    Start date: 2011-06-29

Pegasys
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-20

Pegasys
    Start date: 2011-06-29
    End date: 2011-06-29

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: date of dicontinuation: 05/jul/2011
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-07-05

Other drugs received by patient: Spironolactone; Lasix; RED Cells Pack; Lortab; Lasix; Rabeprazole Sodium; Alprazolam; Diphenhydramine HCL; Protonix; Lithium Carbonate; Promethazine; Zolpidem; Epoetin Alfa; Acetaminophen



Possible Pegasys side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04

Patient: 62 year old male

Reactions: Dysgeusia, Fatigue, Chest Discomfort, Dyspnoea, Nausea, Anaemia, Chest Pain

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribasphere
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01



Possible Pegasys side effects in 55 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-02

Patient: 55 year old female

Reactions: Dysgeusia, Fatigue, Nausea, Anaemia, Gastrooesophageal Reflux Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-04-01

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18



Possible Pegasys side effects in male

Reported by a physician from Australia on 2012-05-31

Patient: male, weighing 88.0 kg (193.6 pounds)

Reactions: Deafness Bilateral

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-12
    End date: 2012-01-24

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-12
    End date: 2012-01-28

Other drugs received by patient: Fungilin; Pristiq



Possible Pegasys side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: male

Reactions: Gait Disturbance

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Victrelis
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-13
    End date: 2012-04-01



Possible Pegasys side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23

Patient: 60 year old male

Reactions: Listless, Nausea, Anaemia, Rash, Abdominal Discomfort, Subretinal Haematoma, Syncope, Fatigue, Gastrointestinal Disorder, Insomnia, Vision Blurred, Dizziness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg; tid; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-28
    End date: 2012-04-30

Other drugs received by patient: Nadolol



Possible Pegasys side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22

Patient: 58 year old male

Reactions: Arthralgia, Hypotension, Dizziness, Headache, Asthenia, Blood Pressure Diastolic Decreased, Abdominal Pain Upper

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Norvasc
    Dosage: 10 mg;qd
    Indication: Product Used FOR Unknown Indication

Pegasys
    Dosage: 180 mcg;qw
    Indication: Hepatitis C
    Start date: 2012-03-22

Ribasphere
    Dosage: 1000 mg;bid
    Indication: Hepatitis C
    Start date: 2012-03-22

Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Other drugs received by patient: Benazepril Hydrochloride W / Hydrochlorothiaz.



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017